In vitro effects of sildenafil and phentolamine, drugs used for erectile dysfunction, on human sperm motility

被引:22
作者
Andrade, JR [1 ]
Traboulsi, A
Hussain, A
Dubin, NH
机构
[1] Union Mem Hosp, Dept Gynecol & Obstet, Baltimore, MD 21218 USA
[2] Univ Kentucky, Coll Pharm, Lexington, KY 40536 USA
关键词
phentolamine; sildenafil; sperm motility;
D O I
10.1067/mob.2000.105406
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The aim of this study was to determine the effects of sildenafil and phentolamine on sperm motility in vitro. STUDY DESIGN: Semen or washed sperm was mixed with Various doses of sildenafil or phentolamine and analyzed for motility during a 30-minute period. The pH was measured for each of the samples tested, Statistical analyses were performed with analysis of variance. RESULTS: A 200-mu g/mL dose of sildenafil had no effect on sperm motility. However, the highest dose (2000 mu g/mL) significantly reduced motility by about 50%. The pH was reduced in this high-dose sample. The lowest dose of phentolamine (20 mu g/mL) had no effect, whereas a dose of 200 mu g/mL resulted in a significant reduction in sperm motility. The highest dose (2000 mu g/mL) stopped virtually all sperm from moving. CONCLUSION: This study demonstrated a direct dose-related effect of phentolamine on reducing sperm motility. Only the highest dose of sildenafil had an effect, which may have been caused by a decline in pH.
引用
收藏
页码:1093 / 1095
页数:3
相关论文
共 11 条
[1]   Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction [J].
Abdallah H.M. .
International Urology and Nephrology, 1998, 30 (5) :617-620
[2]  
Boolell M, 1996, Int J Impot Res, V8, P47
[3]   Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro [J].
Chuang, AT ;
Strauss, JD ;
Murphy, RA ;
Steers, WD .
JOURNAL OF UROLOGY, 1998, 160 (01) :257-261
[4]  
FALLON B, 1995, UROL CLIN N AM, V22, P833
[5]   Oral sildenafil in the treatment of erectile dysfunction [J].
Goldstein, I ;
Lue, TF ;
Padma-Nathan, H ;
Rosen, RC ;
Steers, WD ;
Wicker, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1397-1404
[6]   A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital [J].
Gueugniaud, PY ;
Mols, P ;
Goldstein, P ;
Pham, E ;
Dubien, PY ;
Deweerdt, C ;
Vergnion, M ;
Petit, P ;
Carli, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1595-1601
[7]   Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro [J].
Jeremy, JY ;
Ballard, SA ;
Naylor, AM ;
Miller, MAW ;
Angelini, GD .
BRITISH JOURNAL OF UROLOGY, 1997, 79 (06) :958-963
[8]  
OLMSTED SS, 2000, IN PRESS FERTIL STER
[9]   DRUGS IN SEMEN [J].
PICHINI, S ;
ZUCCARO, P ;
PACIFICI, R .
CLINICAL PHARMACOKINETICS, 1994, 26 (05) :356-373
[10]   PAPAVERINE-PHENTOLAMINE AND PROSTAGLANDIN EL VERSUS PAPAVERINE-PHENTOLAMINE ALONE FOR INTRACORPOREAL INJECTION THERAPY - A CLINICAL DOUBLE-BLIND-STUDY [J].
SHENFELD, O ;
HANANI, J ;
SHALHAV, A ;
VARDI, Y ;
GOLDWASSER, B .
JOURNAL OF UROLOGY, 1995, 154 (03) :1017-1019